https://doi.org/10.1038/nature12347
H
Hiroaki Kanda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
179
Papers
5.5K
Citations
26
h-index
47
i10-index
Hiroaki Kanda is an academic researcher from Saitama Cancer Center. The author has contributed to research in topics: Gut microbiota and health & Sarcoma Diagnosis and Treatment & Diet and metabolism studies. The author has an h-index of 26, co-authored 153 publications.
ORCID: 0000-0002-4602-5938Papers by this author
worksObesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 · Nature · 2,133 citations
Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2017 · Cancer Discovery · 454 citations
https://doi.org/10.1158/2159-8290.cd-16-0932
Ablation of the p16INK4a tumour suppressor reverses ageing phenotypes of klotho mice
2015 · Nature Communications · 71 citations
https://doi.org/10.1038/ncomms8035
Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein
2015 · Scientific Reports · 60 citations
https://doi.org/10.1038/srep10024
Utility of <sup>211</sup>At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model
2021 · Journal of Nuclear Medicine · 27 citations
https://doi.org/10.2967/jnumed.120.249300
Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis
2020 · iScience · 25 citations
https://doi.org/10.1016/j.isci.2020.101306
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat